270 related articles for article (PubMed ID: 6099858)
1. Interactions between virus and antiviral compounds in the host cell.
Harmenberg J
Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
[No Abstract] [Full Text] [Related]
2. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
Shigeta S; Yokota T
Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
[No Abstract] [Full Text] [Related]
3. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
[No Abstract] [Full Text] [Related]
4. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
[TBL] [Abstract][Full Text] [Related]
5. In vitro sensitivity of macropodid herpesvirus 2 to selected anti-herpetic compounds.
Smith G
J Wildl Dis; 1996 Jan; 32(1):117-20. PubMed ID: 8627922
[TBL] [Abstract][Full Text] [Related]
6. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
[No Abstract] [Full Text] [Related]
7. 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Schnute ME; Anderson DJ; Brideau RJ; Ciske FL; Collier SA; Cudahy MM; Eggen M; Genin MJ; Hopkins TA; Judge TM; Kim EJ; Knechtel ML; Nair SK; Nieman JA; Oien NL; Scott A; Tanis SP; Vaillancourt VA; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2007 Jun; 17(12):3349-53. PubMed ID: 17434304
[TBL] [Abstract][Full Text] [Related]
8. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
Harmenberg J; Källander CF; Gronowitz JS
Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of antiviral resistance among the herpesvirus group].
Reina J
Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
[No Abstract] [Full Text] [Related]
10. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Fyfe JA; McKee SA; Keller PM
Mol Pharmacol; 1983 Sep; 24(2):316-23. PubMed ID: 6310366
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
Katz E; Rosenblat O; Pisanty S
Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
[TBL] [Abstract][Full Text] [Related]
12. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
Cheng YC; Dutschman G; De Clercq E; Jones AS; Rahim SG; Verhelst G; Walker RT
Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
[No Abstract] [Full Text] [Related]
13. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
[TBL] [Abstract][Full Text] [Related]
14. Biochemical aspects of the selective antiherpes activity of nucleoside analogues.
De Clercq E
Biochem Pharmacol; 1984 Jul; 33(14):2159-69. PubMed ID: 6147138
[No Abstract] [Full Text] [Related]
15. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
16. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy.
Loregian A; Palù G
Clin Microbiol Infect; 2005 Jun; 11(6):437-46. PubMed ID: 15882193
[TBL] [Abstract][Full Text] [Related]
18. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
[TBL] [Abstract][Full Text] [Related]
19. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
Jamieson AT; Gentry GA; Subak-Sharpe JH
J Gen Virol; 1974 Sep; 24(3):465-80. PubMed ID: 4372299
[No Abstract] [Full Text] [Related]
20. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
